Artificial DNA can control release of active ingredients from drugs
A drug with three active ingredients that are released in sequence at specific times: Thanks...
SpringWorks and GSK sign clinical trial collaboration agreement
SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s (GSK)...
Velabs Therapeutics Announces 3 Million Series B Financing to Advance its Functional Antibody Screening...
Velabs Therapeutics GmbH, a leader in rapid screening of functional therapeutic antibodies, announced the closing...
AbbVie Announces US FDA Lifts Partial Clinical Hold on Phase 3 Study of Venetoclax...
AbbVie , a research-based global biopharmaceutical company announced that the U.S. FDA has lifted the...
Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities
Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of...
Pharmacosmos A/S announces publication of positive results from the FERWON-NEPHRO study
Pharmacosmos A/S announces publication of positive results from the FERWON-NEPHRO study and the pre-specified pooled...
Quanticate Expands Presence in North America with New Toronto Office
Quanticate, a leading global data-focused clinical research organisation(CRO), has announced plans to expand its presence...
ideaPoint Announces Enhanced Partnering Software and Mobile App at BIO International
Anaqua’s ideaPoint, a leading provider of innovation management solutions, announced the launch of partnering software...
World Courier and GE Healthcare Collaborate to Drive Commercialization of Cell and Gene...
GE Healthcare and World Courier, a part of AmerisourceBergen, are combining their expertise in manufacturing...
FDA Approves Galafold for the Treatment of Certain Adult Patients with Fabry Disease
Amicus Therapeutics announced that the U.S. FDA has granted accelerated approval of Galafold™ (migalastat) 123...
